Last edition
News about "Acute Myeloid Leukemia "
MiNK Therapeutics collaborates with C-Further consortium to develop PRAME-targeted TCR-engineered iNKT cell therapy for paediatric cancers, aiming to deliver innovative immunotherapy options for children with limited treatment alternatives.
Acute Myeloid Leukemia | 12/03/2026 | By News Bureau
TuHURA Biosciences Files IND for TBS-2025 in Relapsed/Refractory mutNPM1 AML
TuHURA Biosciences has filed an IND with the FDA to evaluate its VISTA-targeting antibody TBS-2025 in combination with a menin inhibitor for relapsed/refractory mutNPM1 AML.
Acute Myeloid Leukemia | 20/02/2026 | By News Bureau | 152
First Patient Dosed in New Beat AML Sub-Study Testing Triplet Therapy
Blood Cancer United launches a new Beat AML sub-study evaluating ficlatuzumab with venetoclax and azacitidine for newly diagnosed older adults with acute myeloid leukemia.
Acute Myeloid Leukemia | 15/01/2026 | By News Bureau | 160
Amgen Acquires UK- based Dark Blue Therapeutics in 840M USD Deal
Amgen’s acquisition of Dark Blue Therapeutics, adds a first-in-class protein degrader programme targeting MLLT1/3-driven acute myeloid leukemia to strengthen its early-stage oncology pipeline.<br />
Acute Myeloid Leukemia | 07/01/2026 | By News Bureau | 108
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy